SCHEMBL263835

SCHEMBL263835

N#Cc1cnc(N)nc1N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.64
CLK4 Q9HAZ1 1/20 0.64
ADORA2A P29274 1/20 0.55
ADORA1 P30542 1/20 0.55
TP53 P04637 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 4/20 0.45
GAA P10253 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
P2RX3 P56373 1/20 0.42
P2RX2 Q9UBL9 1/20 0.42
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1579901 0.78 ADORA2A (0.51) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL3356613 0.78 CSNK1A1 (0.55) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL28939398 0.78 CSNK1A1 (0.60) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL584580 0.78 CSNK1A1 (0.60) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL1143429 0.78 CSNK1A1 (1.00) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL31492947 0.78 CSNK1A1 (0.60) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL1143690 0.78 CSNK1A1 (0.60) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL19837459 0.78 CSNK1A1 (0.60) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL14757551 0.78 ADORA2A (0.51) CSNK1A1CLK4ADORA2AADORA1TP53
SCHEMBL23270231 0.77 P2RX3 (0.42) CSNK1A1CLK4ADORA2AADORA1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122006472-A Preparation method of chlorine-resistant nanofiltration membrane and chlorine-resistant nanofiltration membrane prepared by preparation method 沃顿科技股份有限公司 2026-05-12 CN claimed
CN-106915735-B Preparation method of nitrogen or metal doped carbon material 广西大学 2020-08-11 CN claimed
CN-106960729-B Preparation method of nitrogen-sulfur co-doped carbon material 广西大学 2020-07-31 CN claimed
CN-106960729-A A kind of preparation method of nitrogen sulphur codope carbon material 广西大学 2017-07-18 CN claimed
CN-1128024-A Process for preparing substituted 4, 6-diamino-5-cyanopyrimidines CIBA GEIGY AG (CH) 1996-07-31 CN claimed
CN-122006472-A Preparation method of chlorine-resistant nanofiltration membrane and chlorine-resistant nanofiltration membrane prepared by preparation method 沃顿科技股份有限公司 2026-05-12 CN disclosed
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same WASHINGTON UNIVERISTY (US) 2025-09-23 US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 US disclosed
US-11021467-B2 Phosphatidylinositol 3-kinase inhibitors GILEAD SCIENCES, INC. (US) 2021-06-01 US disclosed
CN-106915735-B Preparation method of nitrogen or metal doped carbon material 广西大学 2020-08-11 CN disclosed
CN-106960729-B Preparation method of nitrogen-sulfur co-doped carbon material 广西大学 2020-07-31 CN disclosed
CN-106938997-B N- (4- replaces phenethyl) acetamides and application thereof 华东理工大学 2019-10-11 CN disclosed
EP-0244360-B1 SUBSTITUTED PYRIMIDINES CIBA-GEIGY AG (CH) 1992-08-19 EP disclosed
US-4783468-A Insecticidal 5-pyrimidine carbonitriles CIBA-GEIGY CORPORATION (US) 1988-11-08 US disclosed
US-4783468-A Insecticidal 5-pyrimidine carbonitriles CIBA-GEIGY CORPORATION (US) 1988-11-08 US disclosed
CN-87103168-A The pyrimidines that replaces 1987-12-16 CN disclosed
EP-0244360-A2 Substituted pyrimidines CIBA-GEIGY AG (CH) 1987-11-04 EP disclosed
EP-0244360-A2 Substituted pyrimidines CIBA-GEIGY AG (CH) 1987-11-04 EP disclosed
US-4568744-A ANTIBACTERICIDES AND DIRUETIC INTERMEDIATES BURROUGHS WELLCOME CO. (US) 1986-02-04 US disclosed
US-4116958-A ORGANIC SYNTHETIC METHODS BENZYLPYRIMIDINE DERIVATIVES BURROUGHS WELLCOME CO. (US) 1978-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME DHFR, DHPS, MTHFD1 CSNK1A1 4353/4885CLK4 4448/4885ADORA2A 3476/4885
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same DHFR, DHPS, MTHFD1 CSNK1A1 4353/4885CLK4 4448/4885ADORA2A 3476/4885
US-11021467-B2 Phosphatidylinositol 3-kinase inhibitors PIK3CA, PIK3C2B, PIK3CB CSNK1A1 63/4885CLK4 449/4885ADORA2A 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.